Shares of RS Group plc (LON:RS1 – Get Rating) have received a consensus rating of “Hold” from the six research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is GBX 1,150 ($14.24).
A number of brokerages recently commented on RS1. Barclays restated an “equal weight” rating and issued a GBX 1,060 ($13.12) target price on shares of RS Group in a research note on Friday, November 4th. Shore Capital restated an “under review” rating on shares of RS Group in a research note on Thursday, November 3rd. Royal Bank of Canada cut their target price on RS Group from GBX 1,300 ($16.10) to GBX 1,250 ($15.48) and set an “outperform” rating for the company in a research note on Friday, November 4th. Finally, JPMorgan Chase & Co. cut their target price on RS Group from GBX 1,050 ($13.00) to GBX 820 ($10.15) and set an “underweight” rating for the company in a research note on Monday, November 7th.
RS Group Price Performance
RS1 opened at GBX 946 ($11.71) on Wednesday. RS Group has a 1-year low of GBX 790 ($9.78) and a 1-year high of GBX 1,169 ($14.47). The company has a current ratio of 2.01, a quick ratio of 1.24 and a debt-to-equity ratio of 29.28. The stock has a market capitalization of £4.47 billion and a price-to-earnings ratio of 1,659.65. The business has a 50 day moving average of GBX 927.60 and a 200-day moving average of GBX 981.19.
RS Group Cuts Dividend
About RS Group
RS Group plc, together with its subsidiaries, distributes various electronics and industrial products in the United Kingdom, the United States, France, Germany, Italy, and internationally. The company provides industrial interconnect and test, industrial automation and control, board-level electronics, and single-board computing products; and tools, consumables, and facilities maintenance products, such as personal protective equipment, site safety products, and 3D printing products.
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Receive News & Ratings for RS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RS Group and related companies with MarketBeat.com's FREE daily email newsletter.